| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |